Drug Profile
Research programme: cyclo-oxygenase-2 inhibitors - Onconova
Alternative Names: COX-2 inhibitors research programme - Onconova; Cyclo-oxygenase-2 inhibitors research programme - Onconova; ON 09250; ON 09300; Onconoxib; Research programme: COX-2 inhibitors - OnconovaLatest Information Update: 23 Feb 2010
Price :
$50
*
At a glance
- Originator Onconova Therapeutics
- Class Heterocyclic compounds
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation
Most Recent Events
- 01 Jul 2004 Compounds from this programme are available for licensing (http://www.onconova.com/)
- 01 Jul 2004 Preclinical trials in Cancer in USA (unspecified route)
- 01 Jul 2004 Preclinical trials in Inflammation in USA (unspecified route)